Possible impact of co-infections of tuberculosis and malaria on the CD4+ cell counts of HIV patients in Nigeria

Annals of African Medicine

Volumn 4, Issue 1, 2005, Pages 10-13

  Audu, Rose A ^a   Onwujekwe, D I ^a   Onubogu, C C ^a   Adedoyin, J A ^a   Onyejepu, N ^a   Mafe, A G ^a   Onyewuche, J ^a   Oparaugo, C ^a   Enwuru, C ^a   Aniedobe, M ^a   Musa, A Z ^a   Idigbe, E O ^a  

^a NIGERIAN INSTITUTE OF MEDICAL RESEARCH   (Nigeria)

Author keywords

CD4+ cell count; Co infection; HIV; Malaria; Tuberculosis

Indexed keywords

CD4 ANTIGEN;

ADULT; ARTICLE; BLOOD BANK; BLOOD DONOR; BLOOD SAMPLING; CONTROLLED STUDY; DATA ANALYSIS; FEMALE; FLUORESCENCE ACTIVATED CELL SORTING; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFORMED CONSENT; LUNG TUBERCULOSIS; LYMPHOCYTE COUNT; LYMPHOCYTE DEPLETION; MAJOR CLINICAL STUDY; MALARIA; MALE; NIGERIA; NONHUMAN; PUBLIC HOSPITAL; STATISTICAL SIGNIFICANCE; SUPERINFECTION;

EID: 25444510685     PISSN: 15963519     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Bentwich Z, Kalinkovich A, Weisman Z. Immune activation is a dominant factor in the pathogenesis of African AIDS. Immunol Today 1995;16:187-191
2. Baum MK, Shor-Posner G, Lu Y. Micronutrients and HIV-1 disease progression. AIDS 1995; 9: 1051-1056
3. Idigbe EO, Ibrahim MM, Onwujekwe DI, Adedoyin JA Otoh I, Audu RA. The trend of HIV/AIDS in clinical and laboratory facilities in Nigeria: 1989-1999. XIV. Proceedings of International AIDS Conference, Barcelona, 2002; Monduzzi Editore 7-11
4. Morrow RH, Colebunders RL, Chin J. Interaction of HIV infection with endemic tropical diseases. AIDS 1998; 3(suppl 1): 579-587
5. Shiratsuchi H, Tsuyuguchi I. Analysis of T cell subsets by monoclonal antibodies in patients with tuberculosis after in vitro stimulation with purified protein derivative of tuberculin. Clin Exp Immunol 1984; 57: 271-278
6. 4 lymphopenia in human tuberculosis. Tubercle 1987; 68: 195-200
7. Haas DW, Des Prez RM. Mycobacterium tuberculosis. In: Mandell G, Douglas R, Bennet J (eds). Principles and practice of infectious diseases. Churchill Livingstone, New York, 1995; 2213-2243
8. Schauf V, Rom WN, Smith KA et al. Cytokine gene activation and modified responsiveness to interleukin-2 in the blood of tuberculosis patients. J Infect Dis 1993; 168:1056-1059
9. Wallis RS, Vjecha M, Amir-Tahmasseb M et al. Influence of tuberculosis on HIV-1: enhanced cytokine expression and elevated beta 2-microglobulin in HIV-1 associated tuberculosis. J Infect Dis 1993; 167: 43-48
10. Toosi Z, Sierra-Madero JG, Blinkhorn RA et al. Enhanced susceptibility of blood monocytes from patients with pulmonary tuberculosis to productive infection with HIV-1. J Exp Med 1993; 177: 1511-1516
11. Lederman MM, Georges DL, Kusner DJ et al. Mycobacterium tuberculosis and its purified protein derivative activate expression of the Human Immunodeficiency Virus. J Acq Immune Defic Syndr 1994; 7: 727-733
12. Whalen C, Horsburgh CR, Hom D et al. Accelerated course of human immunodeficiency virus infection after tuberculosis. Am J Resp Crit Care Med 1995; 151: 129-135
13. French N, Gilks CF. HIV and malaria, do they interact? Trans R Trop Med Hyg 2000; 94: 233-237
14. Whitworth J, Morgan D, Quigley M et al. Effect of HIV-1 and increasing immunosupression on malaria parasitaemia and clinical episodes in adults in rural Uganda: a cohort study. Lancet 2000; 356: 1051-1056
15. Worku S, Bjorkman A. Troye-Blomberg M, Jemaneh L, Barnet A, Christensonn B. Lymphocyte activation and subset redistribution in the peripheral blood in acute malaria illness: distinct T cell patterns in Plasmodium falciparum and P. vivax infections. Clin Exp Immunol 1997; 108: 34-41
16. Wahlgren M, Abrams JS, Fernandez V et al. Adhesion of Plasmodium falciparum- infected erythrocytes to human cells and secretion of cytokines. Scand J Immunol 1995; 42: 626
17. + T cells is markedly enhanced in the setting of antigen-specific immune activation. J Exp Med 1996; 183: 687-692
18. Mellors JW, Rinaldo CR, Gupta P, White RM, Todd JA, Kingsley LA. Prognosis in HIV-1 infection predicted by the quantity of virus in plasma. Science 1996; 272: 1167-1170
19. + T-lymphocyte counts in Human Immunodeficiency Virus (HIV) infected and healthy Nigerian population. Nigeria Medical Practitioner 2001; 39: 53-56
20. + T-lymphocyte counts in patients with Human Immunodeficiency Virus type 1 (HIV-1) and healthy population in Jos, Nigeria. Niger Postgrad Med J 2003; 10: 135-139
21. Balter M. How does HIV overcome the body's T-cell bodyguards? Science 1997; 278: 1399-1400
22. French N, Nakiyingi J, Lugada E, Watera C, Whitworth JAG, Gilks CF. Increasing rates of malarial fever with deteriorating immune status in HIV-1-infected Ugandan adults. AIDS 2001; 15: 899-906
23. Kivihya-Ndugga LE, Ochola JJ, Otieno G, Muthami LN, Gathua S. Clinical and immunological markers in Kenyan pulmonary tuberculosis patients with and without HIV-1. East Afr Med J 1994; 71: 373-375
24. + lymphocyte count in African patients co-infected with HIV and tuberculosis. J Acq Immune Defic Syndr Hum Retrovirol 1995; 8: 386-391